• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒感染的血清分型:定义、与病毒基因亚型的关系及检测评估。联合国艾滋病规划署1型人类免疫缺陷病毒分离与特征鉴定网络。

Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.

作者信息

Cheingsong-Popov R, Osmanov S, Pau C P, Schochetman G, Barin F, Holmes H, Francis G, Ruppach H, Dietrich U, Lister S, Weber J

机构信息

Department of Genito-Urinary Medicine and Communicable Diseases, Imperial College School of Medicine at St Mary's, London, United Kingdom.

出版信息

AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):311-8. doi: 10.1089/aid.1998.14.311.

DOI:10.1089/aid.1998.14.311
PMID:9519892
Abstract

V3 serotyping refers to a system based on binding of antibody in patient sera to V3-loop peptides derived from HIV-1 env genetic subtypes. The V3x serotype represents reactivity of serum from an HIV-1-infected patient (regardless of viral genetic subtype), which reacts preferentially to a V3 peptide derived from the X subtype sequence. We have classified HIV-1 serotypes, determined the relationship between the HIV-1 V3 serotypes and viral genetic subtypes in a large study (n = 125), and evaluated the performance of three different V3 peptide-binding assays. Seven HIV-1 V3 serotypes were identified: A, B, B-Br, B-Th, C, D, and E. Serotypes B-Br and B-Th represent sera that react specifically to peptides derived from Brazilian B (B-Br, GWGR) and Thai B (B-Th, GPGQ) strains. The HIV-1 V3 B, C, and E serotypes correlated closely with their viral env genetic subtypes; 19-26 of 32 B sera (59-79%), 3-4 of 4 C sera (75-100%), and 19-22 of 23 E sera (83-96%) were identified as serotypes B, C, and E, respectively. In contrast, two major V3 serotypes were classified in A sera: A (14-18 of 36 [40-50%]) and C (12-19 of 36 [33-54%]). Similarly, two major V3 serotypes were classified in D sera: B (6-10 of 20 [30-50%]) and D (9-12 of 20 [45-60%]). Serotyping of subtype E sera showed the best concordance with genetic subtypes by all assays. Overall, HIV-1 V3 serotyping produced consistent results among three laboratories. However, HIV-1 V3 serotypes do not distinguish all HIV-1 genetic subtypes. The relative biological significance of the V3 serotypes remains to be elucidated.

摘要

V3血清分型是指一种基于患者血清中的抗体与源自HIV-1 env基因亚型的V3环肽结合的系统。V3x血清型代表来自HIV-1感染患者的血清反应性(无论病毒基因亚型如何),其优先与源自X亚型序列的V3肽发生反应。我们在一项大型研究(n = 125)中对HIV-1血清型进行了分类,确定了HIV-1 V3血清型与病毒基因亚型之间的关系,并评估了三种不同的V3肽结合检测方法的性能。鉴定出七种HIV-1 V3血清型:A、B、B-Br、B-Th、C、D和E。血清型B-Br和B-Th代表分别对源自巴西B(B-Br,GWGR)和泰国B(B-Th,GPGQ)毒株的肽具有特异性反应的血清。HIV-1 V3 B、C和E血清型与其病毒env基因亚型密切相关;32份B血清中有19 - 26份(59 - 79%)、4份C血清中有3 - 4份(75 - 100%)、23份E血清中有19 - 22份(83 - 96%)分别被鉴定为血清型B、C和E。相比之下,A血清中分为两种主要的V3血清型:A(36份中的14 - 18份[40 - 50%])和C(36份中的12 - 19份[33 - 54%])。同样,D血清中分为两种主要的V3血清型:B(20份中的6 - 10份[30 - 50%])和D(20份中的9 - 12份[45 - 60%])。通过所有检测方法,E亚型血清的血清分型与基因亚型的一致性最佳。总体而言,HIV-1 V3血清分型在三个实验室之间产生了一致的结果。然而,HIV-1 V3血清型并不能区分所有的HIV-1基因亚型。V3血清型的相对生物学意义仍有待阐明。

相似文献

1
Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.1型人类免疫缺陷病毒感染的血清分型:定义、与病毒基因亚型的关系及检测评估。联合国艾滋病规划署1型人类免疫缺陷病毒分离与特征鉴定网络。
AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):311-8. doi: 10.1089/aid.1998.14.311.
2
Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.1988年至1993年间,在感染了1型艾滋病毒的埃塞俄比亚人中,V3环抗体识别模式没有变化的证据。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1551-6. doi: 10.1089/aid.1994.10.1551.
3
HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.坦桑尼亚样本的HIV-1 V3血清分型:与基因亚型不匹配的可能原因
AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):139-49. doi: 10.1089/aid.1998.14.139.
4
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.通过抗体与V3环结合对1型艾滋病毒进行血清分型:与病毒基因型的关系。世界卫生组织艾滋病毒分离与鉴定网络。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1379-86. doi: 10.1089/aid.1994.10.1379.
5
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.V3 环肽酶免疫测定血清学分型与基因测序之间缺乏相关性。
AIDS. 1998 Aug 20;12(12):1405-12. doi: 10.1097/00002030-199812000-00001.
6
Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.赤道几内亚1型O组HIV分离株的包膜序列变异性和血清学特征
AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):995-1005. doi: 10.1089/aid.1997.13.995.
7
Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.俄罗斯、白俄罗斯和立陶宛不同风险群体中同时引入不同的HIV-1亚型。
AIDS. 1995 May;9(5):435-9.
8
Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.通过V3肽血清分型对A至E亚型的HIV-1感染进行快速分组及其与序列分析的关系。
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1658-64. doi: 10.1006/bbrc.1994.2858.
9
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.乌干达抗血清与人免疫缺陷病毒1型V3环表位编码肽的反应
AIDS Res Hum Retroviruses. 1994 May;10(5):577-83. doi: 10.1089/aid.1994.10.577.
10
HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.1型人类免疫缺陷病毒E亚型感染且V3环血清学呈广泛、双重(B/E)型的患者具有增加的交叉中和抗体。
AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):69-79. doi: 10.1089/088922201750056807.

引用本文的文献

1
Dynamic Characteristics and HIV Infection of Men who have Sex with Men from 2011 to 2017 in Yinchuan, Ningxia, China.2011年至2017年中国宁夏银川男男性行为者的动态特征与HIV感染情况
Curr HIV Res. 2018;16(5):364-373. doi: 10.2174/1570162X17666190119094035.
2
Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.通过LightCycler实时聚合酶链反应检测纯化CD4 +细胞中1型人类免疫缺陷病毒(HIV-1)前病毒DNA载量。
BMC Infect Dis. 2005 Mar 21;5:15. doi: 10.1186/1471-2334-5-15.
3
Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.
对人类免疫缺陷病毒1型A亚型和B亚型V3结构域具有交叉反应性的抗体在喀麦隆患者血清中很常见,但其中和活性通常受到表位掩盖的限制。
J Virol. 2005 Jan;79(2):780-90. doi: 10.1128/JVI.79.2.780-790.2005.
4
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.在对奈非那韦产生耐药性的过程中,1型人类免疫缺陷病毒C亚型不会优先选择D30N突变。
Antimicrob Agents Chemother. 2004 Jun;48(6):2159-65. doi: 10.1128/AAC.48.6.2159-2165.2004.
5
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.比较B亚型和C亚型CCR5嗜性1型人类免疫缺陷病毒分离株的体外适应性。
J Virol. 2003 Jan;77(2):1021-38. doi: 10.1128/jvi.77.2.1021-1038.2003.
6
V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.人类免疫缺陷病毒2型感染的V3血清学分型并不相关。
J Clin Microbiol. 2001 Oct;39(10):3803-7. doi: 10.1128/JCM.39.10.3803-3807.2001.
7
Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.基因亚型、体液免疫与1型人类免疫缺陷病毒疫苗研发
J Virol. 2001 Jul;75(13):5721-9. doi: 10.1128/JVI.75.13.5721-5729.2001.
8
One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.用于鉴定和区分1型人类免疫缺陷病毒A、B和C亚型以及循环重组型AE和AG的单管实时等温扩增检测法
J Clin Microbiol. 2001 May;39(5):1895-902. doi: 10.1128/JCM.39.5.1895-1902.2001.
9
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.恒河猴中疫苗诱导产生的V3环特异性抗体以及对表达原发性患者人类免疫缺陷病毒1型分离株包膜的猿猴-人类免疫缺陷病毒的控制。
J Virol. 2001 May;75(9):4165-75. doi: 10.1128/JVI.75.9.4165-4175.2001.
10
Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.评估美国获批的用于检测M组病毒变体的人类免疫缺陷病毒免疫测定法。
J Clin Microbiol. 2001 Mar;39(3):1017-20. doi: 10.1128/JCM.39.3.1017-1020.2001.